Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advanced Cell Technology, Inc.
CORRECTING and REPLACING Advanced Cell Technology and Collaborators at the Casey Eye Institute Present Promising Data Supporting Safety and Efficacy of Stem Cell Therapy to Combat Retinal Disease
July 3rd, 2009
Link to article should read: http://www3.interscience.wiley.com/cgi-bin/fulltext/122455604/PDFSTART (sted http://www3.interscience.wiley.com/journal/121640180/issue'CRETRY=1&SRETRY=0) The corrected release reads: ADVANCED CELL TECHNOLOGY AND COLLABORATORS AT THE CASEY EYE INSTITUTE PRESENT PROMISING DATA SUPPORTING SAFETY AND EFFICACY OF STEM CELL THERAPY TO COMBAT RETINAL DISEASE Study suggests hESCs could serve as a safe source of cells to treat diseases of the eye Advanced Cell Technology, Inc. (OTC:ACTC) and its collaborators at OHSU reported the long-term safety and efficacy of human embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) produced under...
Source: Health Business Week (2009-07-03)
|
